Markets
Stocks
Funds
Sectors
Tools
Treasury & Bonds
Overview
Market News
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
My Portfolio
Pieris Pharma
(NQ:
PIRS
)
3.070
USD
+0.080 (+2.68%)
Official Closing Price
/ Updated:
4:42 PM EST, Feb 15, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
369,200
Open
3.010
Bid (Size)
3.010 (1)
Ask (Size)
5.400 (5)
Prev. Close
2.990
Today's Range
2.910 - 3.150
52wk Range
2.390 - 9.312
Shares Outstanding
53,980,359
Dividend Yield
N/A
Performance
YTD
+5.14%
+5.14%
1 Month
+8.87%
+8.87%
3 Month
-11.78%
-11.78%
6 Month
-39.69%
-39.69%
1 Year
-65.39%
-65.39%
Top News
More News
New Research: Key Drivers of Growth for Martin Midstream Partners, Galectin Therapeutics, Mountain Province Diamonds, MINDBODY, Pareteum, and Pieris Pharmaceuticals — Factors of Influence, Major Initi
November 27, 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Martin Midstream...
Read More
from
GlobeNewswire News Releases
Pieris Pharmaceuticals to Present at Investor Conferences in November
November 08, 2018
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and...
Read More
from
GlobeNewswire News Releases
More News
Read More
Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 07, 2018
from
GlobeNewswire News Releases
Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018
October 31, 2018
from
GlobeNewswire News Releases
Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors
October 25, 2018
from
GlobeNewswire News Releases
First Week of September 20th Options Trading For Pieris Pharmaceuticals (PIRS)
February 01, 2019
category
Stocks
from
Market News Video
New Research Coverage Highlights Dorian LPG, Avadel Pharmaceuticals, Pieris Pharmaceuticals, Resolute Energy, American Public Education, and THL Credit — Consolidated Revenues, Company Growth, and Exp
October 16, 2018
from
GlobeNewswire News Releases
IWO's Underlying Holdings Imply 27% Gain Potential
January 25, 2019
category
ETFs
from
ETF Channel
Analysts Anticipate 25% Gains Ahead For IEIH
November 20, 2018
category
ETFs
from
ETF Channel
We Did The Math IEIH Can Go To $32
October 16, 2018
category
ETFs
from
ETF Channel
48 Biggest Movers From Friday
December 31, 2018
category
News
,
BLFS
,
IO
, and 60 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.